From scientific idea to company development, I help biotechs structure their business, deliver operational priorities and prepare for fundraising in Europe and the United States.
A focused assignment or fractional support to strengthen your teams and execute your strategy.
HR and corporate strategy
Team organisation, HR needs, governance and corporate strategy.
BD, partnerships and IP strategy
Business development, partner assessment, intellectual property strategy and value creation.
The next inflection point
Identify the next scientific or financial inflection point. Prioritise deliverables, organise execution and prepare the next stage, including the next funding round.
Identify the next inflection point: scientific validation, a partnership or funding. Then define the actions, deliverables and resources needed to reach it.
Define the next value-creating milestone for the company, the expected outcomes and the criteria for deciding what comes next.
Inflection point, timeline and success criteria
02
Put the essentials in place
Prioritise actions and bring together the resources, expertise, partnerships and funding needed to deliver the work required to reach that milestone.
Action plan, deliverables, responsibilities and budget
03
Manage delivery to the next milestone
Work with your teams on execution, track deliverables and resolve blockers. At each milestone, reassess the path towards the next inflection point.
Progress reviews and preparation for the next stage
Sami EllouzeFounder · BIOPILOT
03 / WHO YOU WILL WORK WITH
Grounded in science. Guided by experience.
I’m Sami Ellouze. My background connects innovation and translational research with strategy and biotech leadership.
At HiFiBiO Therapeutics, I progressed from an engineering role in microfluidics and antibody screening to Deputy CEO France. I led multidisciplinary teams and developed scientific and clinical collaborations.
I also led HiFiBiO’s global innovation function, with a strong focus on translational research: connecting scientific advances and biomarkers with therapeutic development priorities.
Through BIOPILOT, I support leaders with management, corporate strategy and fundraising preparation in Europe and the United States. As CEO of NBX Biosciences, my responsibilities include corporate structuring, scientific and financial roadmaps, and fundraising preparation.
2014 — 2025
HiFiBiO Therapeutics
From engineer to Deputy CEO France. Group-wide innovation leadership and translational research.
SINCE 2025
BIOPILOT
Management and corporate strategy consulting. Fundraising preparation support.
SINCE 2026
NBX Biosciences · CEO
Corporate structuring, scientific and financial roadmaps, and fundraising preparation.
I work on behalf of consulting firms on biotech and life sciences client engagements, strengthening their teams or taking responsibility for a defined workstream.
Specialist support in strategy, science, management and execution
Embedded in your team or under your firm’s brand, as agreed
Confidentiality, responsibilities and commercial terms agreed together
Rates are for business clients and exclude VAT. Scope, deliverables, timelines and billing arrangements are agreed before each assignment.
05 / LET’S DISCUSS YOUR PROJECT
What is your next step?
An idea to turn into a company, a fundraising round to prepare, or a priority to deliver after funding? Let’s discuss your priorities and the actions needed.
Tell me what you need using the form. I will use your contact details to get back to you for an initial discussion.
Based in the Paris region · Supporting companies in Europe and the United States